Screening levels of vitamin E in the blood could help to improve the diagnosis of Alzheimer’s Disease, according to new research that suggests the vitamin may also aid in protection.
The study evaluated the use of magnetic resonance imaging (MRI) and measures of plasma levels of vitamin E forms -including all eight natural vitamin E congeners (four tocopherols and four tocotrienols) -in differentiating individuals with Alzheimer’s disease (AD) and mild cognitive impairment (MCI) from cognitively intact control (CTL) subjects.
The new study reports that both AD and MCI patients had lower blood plasma levels of different vitamin E isomers, compared to CTL subjects.
According to the researchers this European study adds further to the
evidence that increased levels of full spectrum vitamin E in the plasma
is beneficial for improvement of cognitive functions especially in
elderly.
Category: Productos
Source: Nutraingredients